Skip to main content
. 2022 Nov 1;26(6):415–425. doi: 10.4196/kjpp.2022.26.6.415

Fig. 5. Effects of MYR administration on locomotor activity in the OFT during SD.

Fig. 5

MYR, myricetin; OFT, open-field test; SAL, saline; WPF, wide platform; ATI, alprazolam.